Dr. Linden et al., Spinal neurokin(3) receptors facilitate the nociceptive flexor reflex via a pathway involving nitric oxide, PAIN, 80(1-2), 1999, pp. 301-308
The present study examined the effects of intrathecal administration of neu
rokinin(3) receptor agonists on the electrically-evoked nociceptive flexor
reflex in decerebrate and spinalized adult rats. The reflex was evoked by s
timulating the isolated sural nerve at an intensity that activates C fibers
and was measured by recording the number of compound potentials in the ips
ilateral hamstring muscles. Intrathecal senktide (1-30 nmol), a neurokinin3
receptor agonist, dose-dependently facilitated the reflex reaching a maxim
um effect of 230% of the baseline reflex at 10 nmol. SR 142801 (60 nmol), a
non-peptide neurokinin3 receptor antagonist, blocked facilitation of the r
eflex induced by 10 nmol senktide, providing further support that the effec
t of senktide is mediated by neurokinin3 receptors. The intrathecal adminis
tration of senktide (10 nmol) did not alter the monosynaptic reflex elicite
d by stimulating the L5 dorsal root at an intensity that was at the thresho
ld for activating A fibers. This indicates that the senktide-induced facili
tation of the nociceptive flexor reflex was not at the level of the motor n
euron. Pretreatment with NG-nitro-L-arginine methyl ester (30 nmol), a nitr
ic oxide synthase inhibitor, attenuated the effect of senktide, indicating
that facilitation of the reflex by senktide is also mediated by the product
ion of nitric oxide. Data from the present work have shown that spinal neur
okinin3 receptors facilitate the nociceptive flexor reflex through a pathwa
y that involves interneurons and the production of NO. Therefore, neurokini
n3 receptors are likely to be involved in enhancing nociceptive neurotransm
ission at the level of the spinal cord. (C) 1999 International Association
for the Study of Pain. Published by Elsevier Science B.V.